Investor Calendar Invites You to the Amarin First Quarter 2016 Earnings Conference Call and Webcast Live on Thursday, May 5, 2016

BEDMINSTER, NJ and DUBLIN, IRELAND / ACCESSWIRE / May 4, 2016 / Amarin Corporation plc AMRN will host a conference call and live webcast to discuss the results of the first quarter 2016, to be held Thursday, May 5, 2016 at 8:00 AM Eastern Time.

To participate in this event, dial 877-407-8033 domestically, or 201-689-8033 internationally, approximately 5 to 10 minutes before the beginning of the call. Additionally, you can listen to the event online at www.investorcalendar.com/IC/CEPage.asp?ID=174934 as well as via the Amarin website (www.amarincorp.com).

If you are unable to participate during the live webcast, the event archive will be available at www.investorcalendar.com or www.amarincorp.com.

You may access the teleconference replay by dialing 877-660-6853 domestically or 201-612-7415 internationally, referencing conference ID # 13635415. The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on June 5, 2016.

About Amarin

Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Amarin's clinical program includes commitment to an ongoing outcomes study. Vascepa(R) (icosapent ethyl), Amarin's first FDA approved product, is a highly-pure, EPA-only, omega-3 fatty acid product available by prescription. For more information about Vascepa visit http://www.vascepa.com. For more information about Amarin visit www.amarincorp.com.

SOURCE: Investor Calendar